store at low temperature
store at -20°C
Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 147.00 | |
5 mg | In stock | $ 446.00 | |
10 mg | In stock | $ 718.00 | |
25 mg | In stock | $ 1,090.00 | |
50 mg | In stock | $ 1,470.00 | |
100 mg | In stock | $ 1,980.00 |
Description | Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer. |
Synonyms | RO 7092284, RG6058-10, MTIG-7192A, RG6058-11, RG-6058 |
Molecular Weight | N/A |
CAS No. | 1918185-84-8 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Tiragolumab 1918185-84-8 Others RO7092284 RG 6058 RO-7092284 RG6058 RO 7092284 RG6058-10 MTIG-7192A RG6058-11 RG-6058 inhibitor inhibit